January 13, 2026
Headlines

Biogen, Eisai get USFDA nod for Leqembi Iqlik Subcutaneous Injection for maintenance dosing for early Alzheimer’s Disease

DRRA01 mins

[ad_1]

Biogen, Eisai get USFDA nod for Leqembi Iqlik Subcutaneous Injection for maintenance dosing for early Alzheimer’s Disease

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News